Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,674
Total Claims
$542K
Drug Cost
362
Beneficiaries
$1,498
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 109,535 Physician Assistant providers
-83%
Opioid rate vs peers
1.6% vs 9.2% avg
+108%
Cost per patient vs peers
$1,498 vs $719 avg
+75%
Brand preference vs peers
11.6% vs 6.7% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
1.6%
Opioid Rate
135
Opioid Claims
$4,745
Opioid Cost
8.9%
Long-Acting Rate
Brand vs Generic
Brand: 1,002 claims · $439K
Generic: 7,616 claims · $101K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 257 | $87K |
| Dulaglutide | 44 | $48K |
| Empagliflozin | 65 | $39K |
| Mirabegron | 104 | $33K |
| Fluticasone/Umeclidin/Vilanter | 48 | $31K |
| Rivaroxaban | 52 | $29K |
| Insulin Glargine,hum.Rec.Anlog | 56 | $22K |
| Linagliptin | 26 | $14K |
| Sitagliptin Phosphate | 23 | $13K |
| Sacubitril/Valsartan | 16 | $7,319 |
| Insulin Detemir | 11 | $6,835 |
| Insulin Glargine,hum.Rec.Anlog | 23 | $6,426 |
| Budesonide/Formoterol Fumarate | 13 | $4,986 |
| Fluticasone/Vilanterol | 12 | $4,783 |
| Insulin Aspart | 17 | $4,703 |
Prescribing Profile
Patient Profile
82
Avg Age
77%
Female
2.36
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data